For losers in the $14 billion bidding war over drugmaker Medivation Inc., the best cure for the mergers and acquisitions blues may be to go shopping.
That’s good news for BioMarin Pharmaceutical Inc., Biogen Inc., Incyte Corp., Clovis Oncology Inc. and Tesaro Inc., which were mentioned by analysts Monday as potential targets for drugmakers that lost out to Pfizer. Shares of all four companies rose following the takeover announcement, partly becau...
06:01 As Schultz Steps Down, Next Starbucks CEO Brings Tech Savvy11
01:02 A company Trump attacked will receive state tax breaks to keep jobs in the U.S13
14:49 Trump warns of ‘retribution’ for companies that offshore jobs, threatening 35 percent tariff11
11:24 Fidel Castro Funeral: Ex-Leader Will Be Laid to Rest Next to Cuban Hero Marti12